Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Smith & Nephew : +Nephew CEO to step down, ex-Roche Diagnostics chief to take over

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/21/2019 | 03:07am EST
FILE PHOTO: Roland Diggelmann attends a news conference in Basel, Switzerland, February 1, 2017, as Roche Diagnostics CEO.

(Reuters) - Artificial hip and knee maker Smith+Nephew Plc said on Monday Namal Nawana would step down as chief executive officer, after just 17 months on the job, while former Roche Diagnostics head Roland Diggelmann would be succeeding him.

In his short time at the helm of the British firm, Nawana, former head of U.S. diagnostics company Alere, overhauled its leadership team and sharpened the company's focus on product divisions to boost development.

In May, Smith+Nephew raised its full-year revenue forecast after reporting a better-than-expected first-half profit, boosted by higher demand and growth in emerging markets.

Diggelmann, who has over 20 years of experience in the orthopaedics and diagnostics sectors, has been serving as a non-executive director on Smith+Nephew's board since March 2018.

Nawana will also step down from Smith+Nephew's board at the end of this mo
nth to take on opportunities outside the United Kingdom, the company said.https://reut.rs/2PbqAHw

(Reporting by Uday Sampath in Bengaluru; Editing by Shounak Dasgupta and Rashmi Aich)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SMITH & NEPHEW PLC
11/11SMITH & NEPHEW : +Nephew launches industry-first OR3O Dual Mobility System utili..
AQ
11/08SMITH & NEPHEW : +Nephew launches industry-first OR3O™ Dual Mobility Syste..
PU
11/05SMITH & NEPHEW : Investor presentation October - December 2019
PU
10/31SMITH & NEPHEW : +Nephew Third Quarter 2019 Trading Report
PU
10/31SMITH & NEPHEW : Trading Statement
PU
10/22EUROPE : European shares rise amid Brexit tussle as focus shifts to earnings
RE
10/21LONDON MARKETS: Pound Dips, FTSE 100 Steady As Boris Johnson's Bid To Hold Ne..
DJ
10/21EUROPE MARKETS: Banks Drive European Markets Higher As Investors Monitor Brex..
DJ
10/21SMITH & NEPHEW : +Nephew CEO steps down over pay, ex-Roche Diagnostics chief to ..
RE
10/21SMITH & NEPHEW : +Nephew CEO to step down, ex-Roche Diagnostics chief to take ov..
RE
More news
Financials (USD)
Sales 2019 5 122 M
EBIT 2019 1 147 M
Net income 2019 618 M
Debt 2019 1 761 M
Yield 2019 1,70%
P/E ratio 2019 30,0x
P/E ratio 2020 23,2x
EV / Sales2019 3,97x
EV / Sales2020 3,72x
Capitalization 18 586 M
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 23,46  $
Last Close Price 21,28  $
Spread / Highest target 33,7%
Spread / Average Target 10,3%
Spread / Lowest Target -14,9%
EPS Revisions
Managers
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations
Graham James Baker Chief Financial Officer & Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW PLC11.37%18 605
STRYKER CORPORATION26.58%75 258
WRIGHT MEDICAL GROUP N.V.8.12%3 737
GLAUKOS CORPORATION11.82%2 301
INSPIRE MEDICAL SYSTEMS, INC.48.26%1 524
JAPAN LIFELINE CO., LTD.13.11%1 111